
Number of shares of BioNTech 2017-2022
In 2022, the number of shares of biotech company BioNTech SE was around 250 million compared to around 260 million shares in the previous year. This statistic illustrates the number of shares of BioNTech SE from 2017 to 2022. On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.